Skip to content

LP SOCIETY

Active
Private limited companyfounded 20242 years activeRue de Beaulieusart(F-E) 251, 6140 Fontaine-l'Evêque, BelgiumKBO/BCE: BE 1006.284.334
Summary

LP SOCIETY has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €37,509 and a net result of €11,913. Its solvency ranks better than 95% of 22,078 sector peers (NACE 47, fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€41,178total assets 2025
Equity
€37,509
Profit
€11,913
Turnover not published (abridged schema)
Financial health
92 Excellent Checked score 2025
Bankruptcy probability, 12 months
0.3%
Structure
Accounts 7 days early0 of 1 deed read
Why 92- Founded in 2024- Size: total assets €41,178+ Liquidity: current ratio 10.57, cash €26,198+ Equity €37,509 (91.1% of total assets)Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 93% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Strong
Solvency 100+9
equity 91.1% of total assets
Liquidity 100+15
short-term debt 8.9% · cash 63.6%
Profitability 100=
return on assets 28.9%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,155 companies)
Last 24 months 03-2025: 1.8% 04-2025: 1.8%● unchanged vs 03-2025 05-2025: 1.9%▲ +0.1 percentage points vs 04-2025 06-2025: 2.2%▲ +0.3 percentage points vs 05-2025 07-2025: 2.3%▲ +0.1 percentage points vs 06-2025highest value 08-2025: 0.5%▼ -1.8 percentage points vs 07-2025 09-2025: 0.5%● unchanged vs 08-2025 10-2025: 0.5%● unchanged vs 09-2025 11-2025: 0.5%● unchanged vs 10-2025 12-2025: 0.5%● unchanged vs 11-2025 01-2026: 0.5%● unchanged vs 12-2025 02-2026: 0.5%● unchanged vs 01-2026 03-2026: 0.6%▲ +0.1 percentage points vs 02-2026 04-2026: 0.6%● unchanged vs 03-2026 05-2026: 0.6%● unchanged vs 04-2026 06-2026: 0.6%● unchanged vs 05-2026 07-2026: 0.7%▲ +0.1 percentage points vs 06-2026 08-2026: 0.3%▼ -0.4 percentage points vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.3%● unchanged vs 09-2026lowest value
Credit up to €3,000 at 30 days acceptable
Liquidity ample (current ratio 10.57 against 2.9 in 2024; short-term debt: 8.9% and cash: 63.6% of total assets), and 8.9% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 92% on solvency, 99% on liquidity, 96% on profitability and 85% on growth.

The bankruptcy probability was computed on 06-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals.
−lowers risk+raises risk○neutral
lowers risk · Liquidity: current ratio 10.57, cash €26,198
NBB · annual accounts
raises risk · Founded in 2024
How long the company has existed counts in the probability; how much depends on the rest of its profile.
KBO
raises risk · Size: total assets €41,178
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
lowers risk · Equity €37,509 (91.1% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
7 days early
2024
6 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 7 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
07-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Liquidity quadruplescurrent ratio 10.57
  3. Annual accounts filedfiscal year 2024 · micro…

Key points

  • Positive: Among the best 6% on solvencysector median 33.9% · 22,078 companies 91.1% View
  • Total assets 20252 fiscal years filed €41,178 View
  • Active since 2024founded 21-02-2024 2 years View

By topic

Financials

Fiscal year
2025
Total assets
€41,178
Profit
€11,913
Solvency
91.1%
Total assets▲ 6.8%
Net result
20242025
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
21-02-2024
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.